Skip to main content
Generix Group S.A. logo

Generix Group S.A. — Investor Relations & Filings

Ticker · GENX ISIN · FR0010501692 LEI · 9695003QNWHLC60H9E89 PA Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 466 across all filing types
Latest filing 2016-04-27 Earnings Release
Country FR France
Listing PA GENX

About Generix Group S.A.

https://www.generixgroup.com/en

Generix Group is a global SaaS company that provides a portfolio of AI-powered, cloud-based solutions to streamline mission-critical digital processes in supply chain, finance, and commerce. The company's software suite is designed to help businesses build collaborative digital networks with their trading partners. Key offerings include Warehouse Management Systems (WMS), Transportation Management, B2B Integration, and automated invoice management. By digitizing the flow of goods and data, Generix Group enables organizations to optimize operations, enhance productivity, and manage end-to-end processes from procurement to payment and from order to delivery.

Recent filings

Filing Released Lang Actions
Generix Group : CA Q4 2015/2016
Earnings Release Classification · 98% confidence The document explicitly states: "Generix Group, éditeur de solutions applicatives pour les écosystèmes industriels, logistiques et commerciaux, publie aujourd'hui son chiffre d'affaires au titre de son exercice 2015/2016." (Generix Group... publishes today its revenue for the fiscal year 2015/2016). It contains detailed, non-audited financial figures (CA - Chiffre d'Affaires) for Q4 and the full 12 months ending March 31, 2016. This content structure—a press release announcing period-end financial results (revenue figures, growth rates, outlook)—is characteristic of an Earnings Release (ER). It is not the comprehensive Annual Report (10-K) nor the detailed Management Discussion & Analysis (MDA), but the initial announcement of the results. The final line mentions the upcoming publication of the 'résultats annuels' (annual results) on May 30th, confirming this document is the preliminary release. Q4 2016
2016-04-27 French
Déclaration de droits de votes et actions au 31 mars 2016
Notice of Dividend Amount Classification · 95% confidence The document is dated April 11, 2016, and explicitly references compliance with Article L. 233-8 II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers (AMF). It presents a table detailing the total number of shares and theoretical voting rights as of March 31, 2016. This structure—a formal notification regarding the total number of shares and voting rights—is a specific regulatory disclosure often required periodically in European markets. Among the provided codes, none perfectly match a 'Total Voting Rights' disclosure, but it is a mandatory regulatory filing. Given the options, 'RNS' (Regulatory Filings) serves as the best general category for mandatory, non-financial, non-management-change regulatory updates that don't fit elsewhere. It is not an AGM, 10-K, ER, or DIRS. It is a specific regulatory disclosure.
2016-04-11 French
Déclaration de droits de votes et actions au 31 janvier 2016
Regulatory Filings Classification · 95% confidence The document is dated February 9, 2016, and explicitly references French regulatory articles (L. 233-8 II du Code de Commerce and article 223-16 du règlement général de l'Autorité des Marchés Financiers - AMF). The content provides a table detailing the total number of shares and theoretical voting rights as of January 31, 2016. This type of mandatory disclosure regarding the total share capital and voting rights structure is a specific regulatory filing, but it does not fit perfectly into the defined categories like 10-K, IR, or ER. It is a specific regulatory disclosure concerning capital structure/voting rights. Given the options, it is a specific regulatory announcement. Since there is no specific code for 'Total Voting Rights Disclosure', and it is not a Director's Dealing (DIRS), Major Shareholding Notification (MRQ), or Share Issue (SHA), the most appropriate fallback for a specific, non-standard regulatory disclosure is 'Regulatory Filings' (RNS). However, upon re-evaluating the definitions, this disclosure is fundamentally about the capital structure and voting rights, which is often grouped with capital changes or specific regulatory notices. Since it is a formal, periodic disclosure of voting rights, and RNS is the general regulatory fallback, RNS is the best fit among the provided codes for this specific French regulatory notice.
2016-02-09 French
Generix Group REV Q3 2015/2016
Earnings Release Classification · 98% confidence The document explicitly states it is an announcement of revenues for the third quarter of the financial year 2015/2016 ("Generix Group... issued today its revenues for the third quarter of its financial year 2015/2016."). It provides key financial highlights, tables summarizing quarterly and nine-month revenues, and discusses business drivers. This structure—a press release format focusing on period-specific financial results (Q3)—is characteristic of an Earnings Release (ER). It is not a comprehensive annual report (10-K) or a detailed interim report (IR), but rather the initial announcement of the period's performance. Q3 2015
2016-01-25 English
Generix Group CA Q3 2015/2016
Earnings Release Classification · 98% confidence The document explicitly states: "Generix Group, éditeur de solutions applicatives pour les écosystèmes industriels, logistiques et commerciaux, publie aujourd'hui son chiffre d'affaires du troisième trimestre de son exercice 2015/2016." (Generix Group... publishes today its revenue for the third quarter of its 2015/2016 fiscal year). It contains detailed, non-audited quarterly revenue figures (CA Q3 2015/2016) and discusses business performance for the period ending December 31st. This content structure—a press release focused on period-specific financial results (revenue, SaaS bookings) but not the full, comprehensive financial statements typically found in a 10-K or a full Interim Report (IR)—is characteristic of an Earnings Release (ER). It is a summary announcement of results, not the full report itself, and it is not a transcript (CT) or a management discussion (MDA) of a full report, but the initial release of the figures. Q3 2015
2016-01-25 French
Bilan semestriel du contrat de liquidité GENERIX
Capital/Financing Update Classification · 99% confidence The document is a short, semi-annual report dated December 31, 2015, detailing the status of a liquidity contract (contrat de liquidité) managed by NATIXIS for GENERIX shares. It compares the current holdings (shares and cash) to the previous semi-annual period (June 30, 2015). This type of regular, periodic update concerning financial instruments or market-making activities, especially when presented as a brief statement rather than a comprehensive financial report, aligns best with the 'Interim / Quarterly Report' (IR) category, as it is a report covering a period shorter than a year. Although it is very specific, it is a formal interim financial disclosure. Given the context of liquidity management reporting, it is a specific type of interim financial disclosure.
2016-01-08 French

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.